Skip to content

Espansione Group at ESCRS 2025

Hall C1, Booth C1.180
Sept, 12 — 16

Copenhagen, Denmark

—Visit us

Get ready to experience the future of ophthalmology with Espansione Group

Step into the Future of Ophthalmology! Discover cutting-edge advancements in Low-level Light Therapy (LM™ LLLT) and Intense Pulsed Light (OPE™ IPL) technology. Witness live demos of our revolutionary devices and see their transformative power in action.

Experience their treatments firsthand to fully understand their benefits and how they can elevate your practice and enhance patient care.

Can’t Wait to Meet Us?

—Meet our experts

Join our booth for our InSight Speech Series led by the leading voices in ophthalmology. Our experts will share their deep knowledge and latest research findings on our groundbreaking technologies.

Don’t miss these sessions to learn from renowned experts invaluable knowledge and practical tips to enhance your practice.

LEGEND
ANTERIOR SEGMENT
SURGERY
POSTERIOR SEGMENT
GLAUCOMA
DERMATOLOGY & AESTHETICS
Sep — Friday, 12th
@ 15:00
JAMES WOLFFSOHN
Managing Signs and Symptoms of DED: Insights from TFOS DEWS III Reports
DED
GIUSEPPE GIANNACCARE
Photobiomodulation in the Management of dry AMD: 12-Month Results from the LightWave I Multicentric Clinical Trail
AMD
Sep — Saturday, 13th
@ 10:00
GIUSEPPE GIANNACCARE & MADALINA TIMOFTE
Low-level Light Therapy for Preventing Postoperative Dry Eye Disease and Improving Cataract Surgery Outcomes
CATARACT
@ 13:00
KARL STONECIPHER
Supervision: all you need is a few new wavelengths to enhance your outcomes
CATARACT
DED
GIUSEPPE GIANNACCARE
Managing Drug-Induced Ocular Surface Disease in Glaucoma Patients: The Role of Low-level Light Therapy
GLAUCOMA
@ 15:00
DAVID PIÑERO LLORENS
Evaluation of the measurements reliability and validity of a novel screening device in healthy and dry eye patients
SCREENING
JORGE VALDEZ-GARCÍA
Dry Eye Triple Therapy: Current Management of Meibomian Gland Disfunction
DED
Sep — Sunday, 14th
@ 10:00
GIUSEPPE GIANNACCARE
Combining IPL with Blue and Red Light Therapy in the Management of Demodex-Associated Blepharitis
DEMODEX
SÒNIA TRAVÉ-HUARTE
Preliminary Results Of A Randomized Double Masked Clinical Trial Investigating The Impact Of Low-Level Light Therapy (LLLT) On The Ocular Microbiome
MICROBIOME
@ 12:00
SHERAZ DAYA
Dry Eye - My Approach
REFRACTIVE
@ 13:00
GIUSEPPE GIANNACCARE
Low-level Light Therapy for Preventing Postoperative Dry Eye Disease and Improving Cataract and Refractive Surgeries Outcomes
CATARACT
GIUSEPPE GIANNACCARE
Photobiomodulation in the Management of dry AMD: 12-Month Results from the LightWave I Multicentric Clinical Trail
AMD
@ 15:00
JAMES WOLFFSOHN
Managing Signs and Symptoms of DED: Insights from TFOS DEWS III Reports
DED
Sep — Monday, 9th
@ 10:00
DAVID PIÑERO LLORENS
Evaluation of the measurements reliability and validity of a novel screening device in healthy and dry eye patients
SCREENING

Join our Scientific Community page, a hub for professionals seeking to advance their expertise. Access our webinar calendar, free scientific documents including the Scientific Compendium, and expert testimonials on LM™ LLLT and OPE™ IPL technologies.

Can’t Wait to Meet Them?

—WHERE TO FIND US

Where to Find Us

@ Hall C1, Booth C1.180

WHERE TO FIND US

In compliance with current regulations, let us know which audience you belong to:

You must fill in the form to download the file.

I want to be updated about Espansione products and services

This field is required.
This field is required.
This field is required.
A valid email address is required.
This field is required.
This field is required.
Select your role (Ophthalmology/Optometry)*
Select your role (Dermatology/Aesthetics)*
Sub-Specialty*
Sub-Specialty*
Other Specialty*
This field is required.
I have read the privacy policy and the terms and conditions of the site
This field is required.
I want to be updated about Espansione products and services. You can unsubscribe at any time, by using the “unsubscribe” feature at the bottom of any communication you receive.

Thank you for contacting us.